PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.555
-0.005 (-0.32%)
At close: Mar 16, 2026, 4:00 PM EDT
1.560
+0.005 (0.32%)
After-hours: Mar 16, 2026, 4:10 PM EDT
PMV Pharmaceuticals Employees
PMV Pharmaceuticals had 54 employees as of December 31, 2025. The number of employees increased by 7 or 14.89% compared to the previous year.
Employees
54
Change (1Y)
7
Growth (1Y)
14.89%
Revenue / Employee
n/a
Profits / Employee
-$1,439,667
Market Cap
82.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 54 | 7 | 14.89% |
| Dec 31, 2024 | 47 | -16 | -25.40% |
| Dec 31, 2023 | 63 | 1 | 1.61% |
| Dec 31, 2022 | 62 | 8 | 14.81% |
| Dec 31, 2021 | 54 | 10 | 22.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Pliant Therapeutics | 171 |
| Seres Therapeutics | 103 |
| PolyPid | 73 |
| aTyr Pharma | 60 |
| Vivani Medical | 37 |
| Gain Therapeutics | 25 |
| iBio, Inc. | 20 |
PMVP News
- 10 days ago - PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 5 months ago - PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation - GlobeNewsWire
- 5 months ago - PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 6 months ago - Small-Cap PMV Pharmaceuticals Cancer Drug Shows Confirmed Responses In 8 Tumor Types - Benzinga
- 6 months ago - PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation - GlobeNewsWire
- 7 months ago - PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 10 months ago - PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 1 year ago - PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights - GlobeNewsWire